Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit

BACKGROUND AND PURPOSE: Most patients at elevated cardiovascular risk receive long-term aspirin (ASA) anti-platelet treatment. The present study specifically addresses the pharmacological interactions between selective COX-2 inhibitors and ASA and the possible consequences for the thrombotic risk du...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kaber, G, Kaiser, B, Baumgärtel-Allekotte, D, Rauch, BH, Noßmann, S, Heim, KH, Weber, AA, Nagy, N, Fischer, JW, Schrör, K
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2011
Assuntos:
Themed Section: Cardiovascular Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188910/
https://ncbi.nlm.nih.gov/pubmed/21457221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2011.01392.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados